Literature DB >> 28944822

Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.

Chuangang Peng1, Qi Yang2, Bo Wei3, Baoming Yuan1, Yong Liu4, Yuxiang Li4, Dawer Gu4, Guochao Yin4, Bo Wang4, Dehui Xu4, Xuebing Zhang4, Daliang Kong5.   

Abstract

The present study aimed to screen potential genes associated with conventional osteosarcoma (OS) and obtain further information on the pathogenesis of this disease. The microarray dataset GSE14359 was downloaded from the Gene Expression Omnibus. A total of 10 conventional OS samples and two non‑neoplastic primary osteoblast samples in the dataset were selected to identify the differentially expressed genes (DEGs) using the Linear Models for Microarray Data package. The potential functions of the DEGs were predicted using Gene Ontology (GO) and pathway enrichment analyses. Protein‑protein interaction (PPI) data were also obtained using the Search Tool for the Retrieval of Interacting Genes database, and the PPI network was visualized using Cytoscape. Module analysis was then performed using the Molecular Complex Detection module. Additionally, the potential microRNAs (miRNAs) for the upregulated DEGs in the most significant pathway were predicted using the miRDB database, and the regulatory network for the miRNAs‑DEGs was visualized in Cytoscape. In total, 317 upregulated and 670 downregulated DEGs were screened. Certain DEGs, including cyclin‑dependent kinase 1 (CDK1), mitotic arrest deficient 2 like 1 (MAD2L1) and BUB1 mitotic checkpoint serine/threonine‑protein kinase (BUB1), were significantly enriched in the cell cycle phase and oocyte meiosis pathway. DEGs, including replication factor C subunit 2 (RFC2), RFC3, RFC4 and RFC5, were significantly enriched in DNA replication and interacted with each other. RFC4 also interacted with other DEGs, including CDK1, MAD2L1, NDC80 kinetochore complex and BUB1. In addition, RFC4, RFC3 and RFC5 were targeted by miRNA (miR)‑802, miR‑224‑3p and miR‑522‑3p. The DEGs encoding RFC may be important for the development of conventional OS, and their expression may be regulated by a number of miRNAs, including miR‑802, miR‑224‑3p and miR‑522‑3p.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28944822     DOI: 10.3892/mmr.2017.7506

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Identification of key genes and pathways in Ewing's sarcoma patients associated with metastasis and poor prognosis.

Authors:  Guoqi Li; Piao Zhang; Wenkan Zhang; Zhong Lei; Jiaming He; Jiahong Meng; Tuoyu Di; Weiqi Yan
Journal:  Onco Targets Ther       Date:  2019-05-27       Impact factor: 4.147

2.  Identifying an Eight-Gene Signature to Optimize Overall Survival Prediction of Esophageal Adenocarcinoma Using Bioinformatics Analysis of ceRNA Network.

Authors:  Yuanyong Wang; Naixin Liang; Zhiqiang Xue; Xinying Xue
Journal:  Onco Targets Ther       Date:  2020-12-22       Impact factor: 4.147

3.  The biological function and clinical significance of STIL in osteosarcoma.

Authors:  Shu-Fan Ji; Sheng-Lian Wen; Yu Sun; Pi-Wei Huang; Hao Wu; Mao-Lin He
Journal:  Cancer Cell Int       Date:  2021-04-15       Impact factor: 5.722

Review 4.  Dysfunction of miR-802 in tumors.

Authors:  Tong Gao; Mengsha Zou; Tiancheng Shen; Shiwei Duan
Journal:  J Clin Lab Anal       Date:  2021-09-24       Impact factor: 2.352

5.  Integrative analysis of expression, prognostic significance and immune infiltration of RFC family genes in human sarcoma.

Authors:  Gen Wu; Jian Zhou; Xi Zhu; Xianzhe Tang; Jie Liu; Qiong Zhou; Ziyuan Chen; Tang Liu; Wanchun Wang; Xungang Xiao; Tong Wu
Journal:  Aging (Albany NY)       Date:  2022-04-29       Impact factor: 5.682

6.  Identification of a six-gene signature with prognostic value for patients with endometrial carcinoma.

Authors:  Yizi Wang; Fang Ren; Peng Chen; Shuang Liu; Zixuan Song; Xiaoxin Ma
Journal:  Cancer Med       Date:  2018-10-10       Impact factor: 4.452

7.  Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways.

Authors:  Zhen Huang; Shenglin Wang; Hongxiang Wei; Hui Chen; Rongkai Shen; Renqin Lin; Xinwen Wang; Wenbin Lan; Rongjin Lin; Jianhua Lin
Journal:  J Cell Mol Med       Date:  2021-08-01       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.